N-[5-[5-cyano-4-[[1-(dimethylamino)-1-oxobutan-2-yl]amino]-2-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide
C20H23N7O2 — CID 121272032
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[5-cyano-4-[[1-(dimethylamino)-1-oxobutan-2-yl]amino]-2-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide
N-[5-[5-cyano-4-[[1-(dimethylamino)-1-oxobutan-2-yl]amino]-2-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide (PubChem CID 121272032) has the molecular formula C20H23N7O2 and a molecular weight of 393.45 g/mol. Its IUPAC name is N-[5-[5-cyano-4-[[1-(dimethylamino)-1-oxobutan-2-yl]amino]-2-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide.
Molecular Properties
| Compound Name | N-[5-[5-cyano-4-[[1-(dimethylamino)-1-oxobutan-2-yl]amino]-2-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide |
|---|---|
| PubChem CID | 121272032 |
| Molecular Formula | C20H23N7O2 |
| Molecular Weight | 393.45 g/mol |
| Exact Mass | 393.19 |
| IUPAC Name | N-[5-[5-cyano-4-[[1-(dimethylamino)-1-oxobutan-2-yl]amino]-2-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide |
| SMILES | CCC(Nc1cc(-c2cnc(NC(=O)C3CC3)cn2)ncc1C#N)C(=O)N(C)C |
| InChI | InChI=1S/C20H23N7O2/c1-4-14(20(29)27(2)3)25-15-7-16(22-9-13(15)8-21)17-10-24-18(11-23-17)26-19(28)12-5-6-12/h7,9-12,14H,4-6H2,1-3H3,(H,22,25)(H,24,26,28) |
| InChIKey | SHLRBIVZKAAIQD-UHFFFAOYSA-N |
| XLogP | 2.04 |
| TPSA | 123.90 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 393.45 |
| LogP ≤ 5 | 2.04 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121272032 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.